Tardive Dyskinesia (TD) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033 thelansis.com

Tardive dyskinesia (TD) is an involuntary neurological movement disorder caused by the use of dopamine receptor blocking drugs prescribed to treat certain psychiatric or gastrointestinal conditions. Tardive dyskinesia is caused by the long-term use of a class of neuroleptics drugs. These drugs are also called antipsychotics or major tranquilizers.
• The occurrence of Tardive dyskinesia (TD) is estimated to be 2%-5% annually, and the condition occurs in 15%-30% of those who receive long-term treatment with APDs.

Thelansis’s “Tardive Dyskinesia (TD) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Tardive Dyskinesia (TD) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Tardive Dyskinesia (TD) across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.
Tardive Dyskinesia (TD) Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.
Read more: Tardive Dyskinesia (TD) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033
Tags: Tardive Dyskinesia (TD), Tardive Dyskinesia (TD) market outlook, Tardive Dyskinesia (TD) competitive landscape, Tardive Dyskinesia (TD) market forecast, Thelansis, Primary market research, KOL insights, Competitive Intelligence (CI)